Madrid, Spain

Andres Gomez

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andres Gomez. Retrieved from https://idiyas.com/inventor/andres-gomez-2kc4hmgg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andres Gomez

Introduction

Andres Gomez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on didemnin compounds. His expertise and dedication to research have led to the development of a unique pharmaceutical formulation.

Latest Patents

Andres Gomez holds 1 patent for a pharmaceutical formulation of a didemnin compound. This stable pharmaceutical composition includes a lyophilized didemnin preparation that contains water-soluble material, along with a reconstitution solution of mixed solvents. This invention showcases his commitment to advancing medical treatments.

Career Highlights

Gomez is associated with Pharma Mar, S.A., a company known for its focus on biotechnology and pharmaceuticals. His work at Pharma Mar has allowed him to explore innovative solutions in drug development, contributing to the company's mission of improving patient outcomes.

Collaborations

Throughout his career, Andres has collaborated with esteemed colleagues such as Bastiaan Nuijen and Jacob Hendrik Beijnen. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Andres Gomez exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the formulation of didemnin compounds, highlight the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…